These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Osmium focuses on small stocks ($100 million to $1 billion) and on long-term holdings (2-4 years, which gives you an advantage in learning more about the company). They have […]
Articles
May 12 Update: The lateset teaser pitch from the Fool is touting this same stock again, only with a different spiel from a different company as they tout the “connected car” instead of the “autonomous car”. I presume they’re just testing different ads to see what works best — this latest one pitches it as: […]
These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Osmium Partners is a pretty young hedge fund, they invest in small cap companies and work actively with company management and aim for 2-4 year holding periods. John Lewis […]
Some more stocks from our list of speculative ideas to run through today, let’s jump right in with a look at Ligand Pharmaceuticals (LGND) and Invensense (INVN), two of the faster-growing stocks I’ve covered that are seeing rapid change, and do a quick check-in on some other tech-related stocks in our speculation list that haven’t […]
I’m traveling today so I’ll try to keep it brief for you (“for a change,” sighs the patient reader) … this morning I had a limit buy order triggered on a stock I haven’t written a lot about for you, and there were also some quarterly reports that have made me think over the last […]
It’s been an interesting year so far — this week has helped to heal some wounds but my personal portfolio has lagged the market for much of the year, thanks largely to some substantial positions in stocks that were sensitive either to interest rate rises (like Retail Opportunity Investments Corp, ROIC, a favorite REIT) or […]
I have a few thoughts to share with my favorite Irregulars today for our Friday File (we also shared a new article from Doc Gumshoe earlier today if you’re interested). Today we’re looking at a few trades I’ve made this week (four buys and one sell), updating thoughts on a couple companies I’ve covered before, […]
As I typically do after attending the Value Investing Congress, I’m selecting one of my favorite ideas from the conference to share with you as our next “Idea of the Month.” The selection process was a little tough this time, because there were several picks that I found pretty compelling — a couple specialty insurance […]
David Nierenberg founded the D3 family of investment funds, which is a focused small cap and micro cap investment group. They profiled one of their interesting ideas this morning to launch the Value Investing Congress, and like many of the stocks they pick it’s a stock that they think gives growth at a discounted price. […]
The following article covers a teaser ad that has just started to be run again by the Motley Fool. Our article was originally published on February 2, 2011 when the ad first started to run, and the ad is substantially the same but the article below has not been updated or revised so some of […]
We have a charming little tradition here at Stock Gumshoe of picking out the stinkiest stock to have been teased over the past year, and calling it our “Turkey of the Year” come Thanksgiving time. It’s not particularly fair — certainly not to turkeys everywhere, and probably not to the newsletter folks who use breathless, […]
We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.
More Info
Comments
No comments.